1/33
Vocabulary flashcards covering key terms, molecules, enzymes, and therapeutic applications related to non-coding RNA, microRNA, and RNA interference.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Non-coding RNA (ncRNA)
RNA molecules that are transcribed but not translated into protein; many regulate gene expression.
microRNA (miRNA)
Endogenous ~22-nt hairpin-derived RNA that guides RISC to repress or degrade complementary mRNA.
Small interfering RNA (siRNA)
~21–23-nt double-stranded RNA (natural or synthetic) that triggers sequence-specific mRNA degradation via RNAi.
RNA interference (RNAi)
Cellular mechanism in which dsRNA initiates sequence-specific silencing of gene expression at the mRNA level.
Double-stranded RNA (dsRNA)
Two complementary RNA strands forming a duplex; essential trigger and substrate for RNAi.
Dicer
RNase III endonuclease that cleaves dsRNA into siRNA/miRNA duplexes and initiates RNAi.
RNA-Induced Silencing Complex (RISC)
Multi-protein complex that, loaded with a guide RNA strand, cleaves or represses target mRNA.
Argonaute (AGO)
Endonuclease core of RISC that performs guide-RNA-directed cleavage of complementary mRNA.
TRBP
Transactivation response element RNA-binding protein; Dicer co-factor aiding miRNA processing.
Gene silencing
Reduction or elimination of gene expression, often via mRNA degradation or translation repression.
Antisense RNA
RNA strand complementary to a sense mRNA that can hybridise and inhibit its translation or stability.
Natural antisense transcription (NAT)
Endogenous production of antisense RNA from the opposite strand (cis) or a distant locus (trans) of a gene.
Long non-coding RNA (lncRNA)
200-nt ncRNA class that modulates diverse cellular processes, often in a cell-type-specific manner.
Piwi-interacting RNA (piRNA)
26–31-nt small RNA that binds Piwi proteins to maintain germ-line genome stability.
Small nucleolar RNA (snoRNA)
60–300-nt RNA species that guide chemical modification and processing of ribosomal RNA.
Small nuclear RNA (snRNA)
~150-nt RNA component of the spliceosome, essential for pre-mRNA splicing.
Chalcone synthase (CHS) co-suppression
Unexpected simultaneous silencing of transgene and endogenous CHS in petunias, early evidence of RNAi.
lin-4 microRNA
First discovered miRNA (in C. elegans) that down-regulates lin-14 mRNA to control developmental timing.
lin-14 mRNA
C. elegans transcript whose 3′UTR contains sites complementary to lin-4 miRNA; repressed during development.
Caenorhabditis elegans (C. elegans)
Model nematode organism pivotal for the discovery of RNAi and microRNA biology.
Promoter
DNA sequence where RNA polymerase binds to initiate transcription of a gene.
Enhancer
Regulatory DNA element that increases transcription levels of associated genes, often via TF binding.
Transcription factor
Protein that binds specific DNA sequences to regulate the rate of gene transcription.
Chromatin
DNA–protein complex whose structural modifications (e.g., histone acetylation) influence gene expression.
DNA methylation
Covalent addition of methyl groups to DNA, usually repressing transcription.
Ribosome
Ribonucleoprotein machine that translates mRNA codons into a polypeptide chain.
Initiation factors
Proteins that assist ribosome assembly on mRNA to start translation.
Post-translational modification
Chemical alteration of proteins (e.g., phosphorylation, ubiquitination) that affects function and stability.
Ubiquitination
Attachment of ubiquitin to proteins, marking them for degradation by the proteasome.
Phosphorylation
Addition of a phosphate group to proteins, modulating activity, localisation or interactions.
Givosiran
Approved siRNA drug that targets hepatic ALAS1 to treat acute intermittent porphyria.
Patisiran
First FDA-approved RNAi therapeutic; siRNA against transthyretin for hereditary amyloidosis.
Fitusiran
GalNAc-conjugated siRNA in clinical trials that lowers antithrombin levels to treat haemophilia.
Inclisiran
Investigational siRNA targeting PCSK9 to reduce low-density lipoprotein cholesterol levels.